eIFUs and animal tissues in devices: UK seeks feedback on EU rules
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is inviting feedback on how it should implement into UK law two EU regulations on: using electronic instructions-for-use (eIFUs) with certain devices, and introducing precautionary measures for devices manufactured using non-viable tissues from Transmissible Spongiform Encephalopathies (TSE)-susceptible species1,2.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.